Opportunity Radar

← Back to search

Grant

NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)

View on Grants.gov ↗ Sign in to save

Type
Grant
Notice type
CA
Agency
National Institutes of Health
Sub-agency
HHS-NIH11
Solicitation #
PAR-27-065
Posted
Aug 31, 2026
Response due
Mar 9, 2029
Archive date
May 8, 2029
CFDA / Assistance listing
93.853
Contact
Exploratory_Efficacy_Trials@ninds.nih.gov
Source
Grants.gov

Description

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). These trials must address questions within the mission and research interests of the NINDS and may include studies of small molecules, biologics, devices as well as surgical, behavioral, diet-based, or rehabilitation therapies. Studies addressing neurological diseases and care across the lifespan are highly encouraged. This notice invites both early- and middle-phase exploratory clinical trials as well as later phase confirmatory Phase 3 or comparative effectiveness clinical trials.

Similar open opportunities